Amedisys Inc (NASDAQ:AMED) — Market Cap & Net Worth
Market Cap & Net Worth: Amedisys Inc (AMED)
Amedisys Inc (NASDAQ:AMED) has a market capitalization of $3.32 Billion ($3.32 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4634 globally and #1495 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amedisys Inc's stock price $100.99 by its total outstanding shares 32887700 (32.89 Million). Analyse cash flow conversion of Amedisys Inc to see how efficiently the company converts income to cash.
Amedisys Inc Market Cap History: 2015 to 2025
Amedisys Inc's market capitalization history from 2015 to 2025. Data shows growth from $1.29 Billion to $3.32 Billion (9.63% CAGR).
Index Memberships
Amedisys Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.14% | #106 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.01% | #500 of 3165 |
|
S&P Midcap 400
MID
|
$3.36 Trillion | 0.12% | #346 of 401 |
Weight: Amedisys Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Amedisys Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amedisys Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.27x
Amedisys Inc's market cap is 1.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
69.07x
Amedisys Inc's market cap is 69.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.29 Billion | $1.28 Billion | -$3.02 Million | 1.01x | N/A |
| 2016 | $1.40 Billion | $1.44 Billion | $37.26 Million | 0.98x | 37.63x |
| 2017 | $1.73 Billion | $1.53 Billion | $30.30 Million | 1.13x | 57.21x |
| 2018 | $3.85 Billion | $1.66 Billion | $119.35 Million | 2.32x | 32.27x |
| 2019 | $5.49 Billion | $1.96 Billion | $126.83 Million | 2.81x | 43.28x |
| 2020 | $9.65 Billion | $2.07 Billion | $183.61 Million | 4.66x | 52.54x |
| 2021 | $5.32 Billion | $2.21 Billion | $209.07 Million | 2.40x | 25.46x |
| 2022 | $2.75 Billion | $2.22 Billion | $118.61 Million | 1.24x | 23.16x |
| 2023 | $3.13 Billion | $2.24 Billion | -$9.75 Million | 1.40x | N/A |
| 2024 | $2.99 Billion | $2.35 Billion | $43.23 Million | 1.27x | 69.07x |
Competitor Companies of AMED by Market Capitalization
Companies near Amedisys Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Amedisys Inc by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Amedisys Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Amedisys Inc's market cap moved from $1.29 Billion to $ 3.32 Billion, with a yearly change of 9.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.32 Billion | +11.23% |
| 2024 | $2.99 Billion | -4.49% |
| 2023 | $3.13 Billion | +13.79% |
| 2022 | $2.75 Billion | -48.39% |
| 2021 | $5.32 Billion | -44.81% |
| 2020 | $9.65 Billion | +75.73% |
| 2019 | $5.49 Billion | +42.53% |
| 2018 | $3.85 Billion | +122.18% |
| 2017 | $1.73 Billion | +23.65% |
| 2016 | $1.40 Billion | +8.42% |
| 2015 | $1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Amedisys Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.32 Billion USD |
| MoneyControl | $3.32 Billion USD |
| MarketWatch | $3.32 Billion USD |
| marketcap.company | $3.32 Billion USD |
| Reuters | $3.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more